Amphastar Pharmaceuticals, Inc.

AMPHPharma

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Activity

Key Events

Details

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Therapeutic Focus

NeurologyHematologyOncologyOtherOphthalmologyMusculoskeletalImmunologyMetabolic & EndocrineRespiratory

Regulatory

20041 event

FDAOct 26

AMPHADASE — AMPHADASE

Application BLA021665 (BLA)

20051 event

FDADec 2

AMPHADASE — HYLENEX RECOMBINANT

Application BLA021859 (BLA)

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)